Small Molecule Tyrosine Kinase Inhibitors of ErbB2/HER2/Neu in the Treatment of Aggressive Breast Cancer
The human epidermal growth factor receptor 2 (HER2) is a member of the erbB class of tyrosine kinase receptors. These proteins are normally expressed at the surface of healthy cells and play critical roles in the signal transduction cascade in a myriad of biochemical pathways responsible for cell gr...
Main Authors: | Richard L. Schroeder, Cheryl L. Stevens, Jayalakshmi Sridhar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/19/9/15196 |
Similar Items
-
Ekspresi HER2/neu(c-ErbB2) pada Kanker Kolorektal
by: Nita Afriani, et al.
Published: (2014-12-01) -
Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers
by: Atif Ali Hashmi, et al.
Published: (2018-08-01) -
Expression of HER2/c-erbB-2, EGFR protein in gastric carcinoma and its clinical significance
by: Cheng Guoxiong, et al.
Published: (2019-05-01) -
The Mysterious Ways of ErbB2/HER2 Trafficking
by: Vibeke Bertelsen, et al.
Published: (2014-08-01) -
Management of HER2-positive breast cancer: A review
by: S Viswanath, et al.
Published: (2016-01-01)